Entering text into the input field will update the search result below

AbCellera Biologics Inc (ABCL) Q3 2022 Earnings Call Transcript

Nov. 08, 2022 9:14 PM ETAbCellera Biologics Inc. (ABCL)
SA Transcripts profile picture
SA Transcripts

AbCellera Biologics Inc (NASDAQ:ABCL) Q3 2022 Earnings Conference Call November 8, 2022 5:00 PM ET

Company Participants

Tryn Stimart - Chief Legal and Compliance Officer

Carl Hansen - Chairman, Chief Executive Officer and President

Andrew Booth - Chief Financial Officer

Conference Call Participants

Do Kim - Piper Sandler

Gaurav Goparaju - Berenberg Capital Markets

Stephen Willey - Stifel Financial Corp.

Gary Nachman - BMO Capital Markets

Antonia Borovina - Bloom Burton


Good afternoon. And welcome to AbCellera's Third Quarter 2022 Business Update Conference Call. My name is Dania, and I'll facilitate the audio portion of today's interactive broadcast. [Operator instructions] At this time, I'd like to turn the call over to Tryn Stimart, AbCellera’s Chief Legal and Compliance Officer.

Tryn Stimart

Thank you. Good afternoon, and welcome to AbCellera's third quarter 2022 business update. We're pleased to have you with us today as we will discuss the results announced in our press release issued just after the market closed today, which you can find on our investor relations website. With me on the call are Dr. Carl Hansen, AbCellera's Chief Executive Officer and President; and Andrew Booth, AbCellera’s Chief Financial Officer. The webcast portion of this call contains a slide presentation that we will refer to during the call. If you are following along on the phone and wish to access the slide portion of this presentation, you may do so on the investor relations section of our website. For those who have accessed the streaming portion of the webcast, please be aware that there may be a delay and that you will not be able to post questions via the web.

The presentation here today may contain forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any forward-looking statements are based

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.